Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

MRKR holding history

Marker Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MRKR overviewAll 13F holders of MRKRFull Q2 2026 holdings

Shares (Q2 2026)
2
Value
$2
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of MRKR by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262$2<0.1%00.0%UnchangedHolders
Q1 20262$2<0.1%−13−86.7%ReducedHolders
Q4 202515$22<0.1%−446−96.7%ReducedHolders
Q3 2025461$412<0.1%+60+15.0%AddedHolders
Q2 2025401$613<0.1%+8+2.0%AddedHolders
Q1 2025393$483<0.1%+35+9.8%AddedHolders
Q4 2024358$1.11K<0.1%−3,050−89.5%ReducedHolders
Q3 20243,408$9.61K<0.1%00.0%UnchangedHolders
Q2 20243,408$18.5K<0.1%−632−15.6%ReducedHolders
Q1 20244,040$17.4K<0.1%+442+12.3%AddedHolders
Q4 20233,598$19.8K<0.1%+1,658+85.5%AddedHolders
Q3 20231,940$8.81K<0.1%00.0%UnchangedHolders
Q2 20231,940$6.01K<0.1%00.0%UnchangedHolders
Q1 20231,940$1.38K<0.1%+31+1.6%AddedConverted for a 1-for-10 splitHolders
Q4 202219,089$5.08K<0.1%+50.0%AddedHolders
Q3 202219,084$7.00K<0.1%−30.0%ReducedHolders
Q2 202219,087$6.00K<0.1%−3,753−16.4%ReducedHolders
Q1 202222,840$10.0K<0.1%−10,960−32.4%ReducedHolders
Q4 202133,800$32.0K<0.1%−2,543−7.0%ReducedHolders
Q3 202136,343$61.0K<0.1%−14,882−29.1%ReducedHolders
Q2 202151,225$143.0K<0.1%+35,865+233.5%AddedHolders
Q1 202115,360$34.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.